FBXW7 and hepatocellular carcinoma: In conclusion, we demonstrated that CASC2 was downregulated in HCC, and could inhibit migration, invasion and EMT progression of HCC cells via CASC2/miR-367/FBXW7 axis, which could be a valuable and promising therapeutic target for HCC in the future.